Vital Therapies (VTL) Tops Q3 EPS by 7c

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.51), $0.07 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
• BMO starts chip stocks coverage: Here are its preferred picks